Amarin | AMRN - Custo de Mercadoria Vendida





Custo de Mercadoria Vendida Alterar Data
AbbVie USD 4.29B 73M 2026-06
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amarin USD 26.05M 1.41M 2025-12
AstraZeneca USD 2.52B 2.73B 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Halozyme Therapeutics USD 108.68M 67K 2026-06
Heron Therapeutics USD 11.12M 795K 2025-12
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
Novartis USD 3.71B 251M 2026-06